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Abstract
Objective:  We aimed to validate the E-CABG classification of postoperative complications in 
patients undergoing coronary artery bypass grafting (CABG).
Design: Retrospective, observational study.
Setting: University hospital.
Participants:  2764 patients with severe coronary artery disease. Complete baseline, operative and
postoperative data were available for who underwent isolated CABG. 
Interventions:  Isolated CABG. 
Measurements and Main Results: The E-CABG complication classification was employed to stratify
the severity and prognostic impact of postoperative adverse events. Primary outcome end-points 
were 30-day, 90-day and long-term all-cause mortality. Secondary outcome end-point was the 
length of intensive care unit stay. Both the E-CABG complication grades and additive score were 
predictive of 30-day (area under the ROC curve 0.866, 95%CI 0.829-0.903 and 0.876, 95%CI 0.844-
0.908, respectively) and 90-day (area under the ROC curve 0.850, 95%CI 0.812-0.887 and 0.863, 
95%CI 0.829-0.897, respectively) all-cause mortality. The complication grades were independent 
predictors of increased mortality at actuarial (Log-rank: p<0.0001) and adjusted analysis 
(p<0.0001, grade 1: HR 1.757, 95%CI 1.111-2.778, grade 2: 2.704, 95%CI 1.664-4.394; grade 3: 
5.081, 95CI% 3.148-8.201). When patients who died within 30 days were excluded from the 
analysis, this grading method was still associated with late mortality (p<0.0001). The grading 
method (p<0.0001) and the additive score (rho, 0.514; p<0.0001) were predictive of the length 
intensive care unit stay.
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Conclusions: The E-CABG postoperative complication classification seems to be a promising tool 
for stratifying the severity and prognostic impact of postoperative complications in patients 
undergoing cardiac surgery.
Abstract word count: 235 words
Key words: Coronary artery bypass; cardiac surgery; complication; classification.
INTRODUCTION
Adult cardiac surgery is associated with significant postoperative mortality and morbidity. 
Moreover, a number of postoperative complications are rather frequent and may compromise the
recovery of patients undergoing cardiac surgery.1,2 Such complications also increase the burden of 
resource use1,2 and may affect late survival.3-7 Few grading methods for complications after major 
surgery have been developed to assess the quality of surgical treatment.8,9 However, these grading
systems are not applicable to patients undergoing cardiac surgery and therefore a specific grading 
method for these patients is needed.  The E-CABG (European multicenter study on coronary artery
bypass grafting) investigators recently proposed a classification of postoperative complications as 
a part of their study protocol.10 The present study was planned to assess the ability of the E-CABG 
complication classification in predicting early and long-term mortality as well as length of intensive
care unit stay of patients undergoing isolated coronary artery bypass grafting (CABG).
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METHODS
Patient population and data collection
The present study included 2764 consecutive patients who underwent isolated CABG from June 
2006 to December 2013 at the Oulu University Hospital, Finland. The study included elective, 
urgent and emergency operations carried out with either off-pump or on-pump technique. 
Patients’ characteristics and operative data are summarized in Table 1. Definition criteria of 
baseline characteristics are according to the EuroSCORE criteria.11
Complete pre- intra- and postoperative data were available in all these patients as obtained from 
institutional electronic cardiac surgery database collecting baseline and operative data as well as 
data on immediate postoperative adverse events.  These data were collected by two research 
nurses and three colleagues. The senior author (FB) has checked all the data along the years. In 
2014 and 2015, this database was again checked by two researchers (EMK and MAM). Twenty-
eight patients without data on serum levels of creatinine were still included in this analysis as in 
most of the cases they died immediately after surgery and their postoperative creatinine level was
not checked. The amount of transfused blood products such as red blood cells (RBCs), platelets 
and solvent/detergent-treated plasma (Octaplas; Octapharma AG, Lachen, Switzerland) was 
retrieved from a prospective electronic hospital registry collecting data on any transfusion of 
blood products. These blood products were administered intraoperatively and throughout the in-
hospital stay. Data on the amount of postoperative blood losses were retrieved from a prospective
electronic registry of our intensive care unit. Glomerular filtration rate (eGFR) was estimated using
the Modification of Diet in Renal Disease (MDRD) formula.12 Clinical variables were defined 
according to the EuroSCORE II definition criteria.12 
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Data on patients’ death were retrieved from Statistics Finland (Tilastokeskus) which collects the 
certificates of death of all inhabitants of Finland. The data for this study were provided up to 
December 31st, 2013. We assume that there are no missing data on immediate and late death of 
this study population.
Operative Techniques
Intermittent antegrade and retrograde blood cardioplegia with KCl  and MgCl at a temperature 
ranging from 10 to 16°C was delivered during on-pump CABG.  Epiaortic ultrasound was 
performed according to the surgeon's preference. The ascending aorta was clamped in case of 
atherosclerotic lesion involving the lateral and/or anterior wall of the ascending aorta.   Proximal 
anastomoses were sutured to the ascending aorta during side clamping or cross-clamping when it 
was considered safe. Octopus stabilizer (Medtronic, Minneapolis, MN) as well as intracoronary 
shunts were routinely used in patients who underwent off-pump CABG.
E-CABG postoperative complication classification method
E-CABG is a European multicenter study currently recruiting patients undergoing isolated CABG. 
The study protocol of this study with detailed definition criteria of baseline, operative and 
postoperative variables has been published previously.10 The E-CABG investigators proposed a 
classification method to stratify the adverse outcome events occurring in these patients. 
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Twenty-four investigators selected and stratified the severity burden of 25 complications or 
interventions for their treatment with potentially negative prognostic impact on the course of 
patients undergoing adult cardiac surgery. Each investigator assigned a score of 0-10 in regards of 
the expected negative impact on outcome of each of these adverse events/interventions. A score 
of 10 was supposed to measure the worst postoperative complication, i.e. patient’s death. The 
medians of scores for each complication/intervention were used to stratify the prognostic 
importance of these adverse events and to develop a four-grade classification of postoperative 
complications (Tab. 2). In case of multiple adverse events occurring in a particular patient, the 
event with the highest score defines the grade to which the patient belongs to. The median scores 
are used as an additive score as well. 
Outcome endpoints
The main outcome measures of this study were all-cause 30-day, 90-day and long-term mortality. 
The secondary outcome end-point was the length of intensive care unit stay. We did not consider 
the length of in-hospital stay as an outcome measure as the timing of discharge of these patients 
reflects the availability of beds at rehabilitation clinics.
Ethical considerations
This study was approved by the Institutional Review Board of the Oulu University Hospital and it 
was not financially supported.
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Statistical analysis 
Statistical analysis was performed with the SPSS v. 22.0 statistical software (IBM Corporation, 1 
New Orchard Road Armonk, New York 10504-1722, United States). No attempt to replace missing 
values was made. Fisher exact test, Chi-square test, Mann-Whitney and Kruskal-Wallis tests were 
used for univariate analysis. Correlation between continuous and ordinal variables was estimated 
by the Spearman’s test. Survival analysis at 90 days was performed including only patients with a 
potential follow-up longer than 3 months. C-statistics were calculated to assess the predictive 
ability of the E-CABG complication classification either as additive score or grades. Kaplan-Meier 
method was used to estimate late survival. Cox proportional hazards analysis was performed to 
adjust the E-CABG complication grades for baseline and operative variables potentially associated 
with poor late survival. These variables were age, eGFR, gender, diabetes, hypertension, prior 
stroke, neurological dysfunction, extracardiac arteriopathy, previous percutaneous coronary 
intervention, previous cardiac surgery, recent myocardial infarction, pulmonary disease, left 
ventricular ejection fraction classes, dialysis, elective/urgent/emergency operation, unstable 
angina requiring nitrates at operating room arrival, critical preoperative status, systolic pulmonary 
pressure, off-pump surgery, number of distal anastomoses and any mammary artery graft. 
Because of imbalance in baseline and operative characteristics of patients in different E-CABG 
classification grades, probabilities (propensity scores) estimated by multinomial regression 
analysis were employed to adjust the risk of early and late mortality in these patients with 
different E-CABG grades (multiple propensity score adjusted analysis).  Propensity scores were 
calculated by a regression model entering all baseline and operative variables listed above. All 
tests were two-sided with the alpha level set at 0.05 for statistical significance. 
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RESULTS
Patients’ characteristics in the overall study population as well as in each E-CABG grade are 
summarized in Table 1. Table 2 summarizes the proportion of patients included in each E-CABG 
complication grade as well as the prevalence of postoperative adverse events in this series. The in-
hospital mortality was 2.4%. The median additive score for each grade indicated that within 
increasing grades of complications also the number of complications increased markedly (grade 1, 
4.0; grade 2, 10.0; grade 3, 21.0). 
This grading method was predictive of the length of stay in the intensive care unit (grade 0, 
1.2±0.6 days; grade 1, 1.6±1.1 days; grade 2, 2.9±2.1 days; grade 3, 4.9±5.2 days, Kruskal-Wallis’s 
test: p<0.0001). The E-CABG complication additive score also correlated significantly with the 
length of stay in the intensive care unit (Spearman’s test: rho, 0.514; p<0.0001).
The E-CABG complication grades were predictive of 30-day (grade 0, 0%; grade 1, 0.4%; grade 2, 
1.7%; grade 3, 14.5%, p<0.0001) and of 90-day mortality (grade 0, 2%; grade 1, 1.1%; grade 2, 
3.7%; grade 3, 21.5%, p<0.0001). Similarly, increasing quintiles of the E-CABG complication score 
were associated with increased 30-day mortality (0%, 0.3%, 1.1%, 3.1%, 12.6%, p<0.0001) as well 
as 90-day mortality (0.2%, 0.6%, 1.3%, 3.9%, 15.0%, p<0.0001). 
Receiver operating characteristics (ROC) analysis confirmed that the E-CABG complication score 
was predictive of 30-day (area under the ROC curve 0.876, 95%CI 0.844-0.908) and 90-day (area 
under the ROC curve 0.863, 95%CI 0.829-0.897, Fig. 1) all-cause mortality. Since the grading 
method is the result of a breakdown of this additive score, ROC analysis was performed also for   
the E-CABG complication grades and showed that these were predictive of 30-day (area under the 
ROC curve 0.866, 95%CI 0.829-0.903) and 90-day (area under the ROC curve 0.850, 95%CI 0.812-
0.887) all-cause mortality.
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The E-CABG complication grades were independent predictors of increased mortality at Kaplan-
Meier (at 5 years: grade 0, 5.5%; grade 1, 11.1%; grade 2, 23.1%; grade 3, 35.3%, Log-rank: 
p<0.0001) (Fig. 2) and Cox regression adjusted analysis (2651 patients included in the multivariate 
model; p<0.0001, grade 1: HR 1.757, 95%CI 1.111-2.778, grade 2: 2.704, 95%CI 1.664-4.394; grade 
3: 5.081, 95CI% 3.148-8.201) (Tab. 2, Fig. 3). 
When patients who died within 30 days were excluded from the analysis, this grading method was 
still associated with late mortality (2562 patients included in the multivariate model; p<0.0001, 
grade 1: HR 1.760, 95%CI 1.1356-2.283, grade 2: 2.936, 95%CI 1.798-4.794; grade 3: 3.209, 95CI% 
1.929-5.338). 
Figure 4 summarizes the unadjusted risk estimates of any early and late mortality for each 
postoperative adverse event. This analysis confirmed that the adverse events included among 
grade 3 complications were associated with a formidable risk of death. Postoperative use of intra-
aortic balloon pump was associated with a very high mortality, likely because extracorporeal 
membrane oxygenation was not in use in this series. Multivariate analysis of the prognostic impact
of these adverse events was not performed because of the risk of overfitting.
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DISCUSSION
The present analysis showed that the E-CABG complication classification performed well when 
used either as a four-grade classification system or as additive score. In fact, both the E-CABG 
complication grades and score were predictive of increased early and late mortality as well as of 
the length of stay in the intensive care unit in patients undergoing isolated CABG. As seen in Figure
4, particularly the adverse events included among grade 3 complications were associated with a 
remarkably increased risk of death. Mortality in patients with postoperative use of intra-aortic 
balloon pump was very high, possibly due to their severely depressed hemodynamic conditions of 
these patients. Indeed, our institutional policy is to use intra-aortic balloon pump only after CABG 
is accomplished and patient has low cardiac output despite optimal inotropic support. 
Extracorporeal membrane oxygenation was not used in this series. 
We did not perform a multivariate analysis to adjust the postoperative complications for baseline 
and operative characteristics because this model would have been too complex and might have 
led to overfitting.  However, risk estimates of several postoperative complications appeared such 
large in univariate analysis that it is not plausible that this was caused solely by bias. Also previous 
studies have reported significant mortality associated with postoperative complications such as 
increased RBC transfusion,13,14 acute kidney injury,4,6 mediastinitis,7 gastrointestinal 
complications,15,16 use of IABP17,18 and atrial fibrillation.3 Welsby et al. investigated patients 
undergoing cardiac surgery with cardiopulmonary bypass and found that, after adjusting for 
preoperative and intraoperative risk factors, the occurrence of non-cardiac complications only and
cardiac complications with other organ involvement significantly increased mortality as well as the
length of stay in the hospital and intensive care unit when compared with cardiac complications 
only.19 
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In addition to the potential independent effect of complications on patients’ survival, there 
seemed to be an interaction between postoperative adverse events. Indeed, the median additive 
score for each grade showed that within increasing grades of complications also the number of 
complications increased significantly as indicated by increased additive score, which was 
particularly high in Grade 3.
The present study showed that a number of complications in lower grades of the classification are 
not likely to affect patients’ survival (Fig. 4) even though also opposite results have been 
reported.5 However, even complications that are considered less severe may cause discomfort to 
the patient and increase the costs for their treatment. Moreover, the synergistic effect of multiple,
even minor, adverse events may also make the lower complication grades of clinically significance 
as seen in the adjusted analyses (Tab. 2).  
An important finding emerging from this analysis was that the risk of death is not limited to the in-
hospital stay: indeed, patients are discharged and die shortly after surgery. In patients classified as
Grade 3, 30-day mortality was 14.5% and 90-day mortality 21.5%. Such a high mortality is not 
acceptable and therefore, considering the potentially preventable nature of a number of these 
postoperative complications, preventive methods should be employed to improve the outcome of 
these patients. Future studies investigating the predictors of Grade 3 complications may identify 
patients at high risk and indicate different treatment strategies. 
Supporting the results of the present study, previous studies emphasized that in-hospital mortality
may not be the most adequate variable to measure the quality of care in patients undergoing 
CABG.20,21 Silber et al. compared 57 American hospitals and observed that reported complication 
rates did not correlate with rates of in-hospital mortality.20 Instead, several hospital characteristics 
generally associated with a higher quality of treatment were associated with rather low mortality 
rates, but higher complication rates.20 
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Also Ghali et al. concluded that complications after CABG are common and may provide more 
informations about hospital quality than in-hospital mortality rates.21
A number of limitations which may affect the results of this study should be acknowledged. The 
retrospective nature of this study is an important limitation of this analysis. However, even if there
are some retrospectively collected data, data on important outcome end-points were retrieved 
from prospective electronic registries which can be considered reliable. Furthermore, data on 
patient’s death are retrieved form a national registry which collects data on all Finnish population. 
This study assessed the prognostic impact of the E-CABG complication classification in patients 
undergoing isolated CABG at a single institution and including patients who underwent either off-
pump or on-pump surgery. Therefore, this classification method should be validated in patients 
operated in other institutions, particularly in those undergoing cardiac procedures other than 
isolated CABG. 
12
CONCLUSIONS
The E-CABG complication classification seems to be a promising tool for stratification of the 
severity and prognostic effect of postoperative complications in patients undergoing isolated 
CABG. This classification method may be of benefit in clinical research in this field. 
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Legend to figures
Figure 1. Receiver operating characteristics curve of E-CABG complication classification score in 
predicting 30-day all-cause mortality. 
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Figure 2. Kaplan-Meier estimates of all-cause mortality according to different E-CABG complication
classification grades (log-rank: p<0.0001).
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Figure 3. Adjusted Cox proportional hazards estimates of all-cause mortality according to different 
E-CABG complication classification grades (p<0.0001, grade 1: HR 1.757, 95%CI 1.111-2.778, grade 
2: 2.704, 95%CI 1.664-4.394; grade 3: 5.081, 95CI% 3.148-8.201).
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Figure 4. Unadjusted estimates of all-cause mortality according to different postoperative adverse 
events included in the E-CABG complication classification. IABP: intra-aortic balloon pump; RBC: 
red blood cell; CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; 
ECMO: extracorporeal membrane oxygenation; HR: hazard ratio; CI: confidence interval.
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Table 1. Baseline and operative characteristics and in-hospital deaths of the study population and subgroups according to the E-
CABG grading.
Overall series 
n=2764
Grade 0   
n= 514
Grade 1   
n= 1425
Grade 2   
n= 466
Grade 3   
n= 359
P-value
Age (years) 67.0±9.1 63.3±8.4 67.1±8.9 69.6±9.4 68.1±8.7 <0.001
Female 582 (21.1) 60 (11.7) 289 (20.3) 151 (32.4) 82 (22.8) <0.001
Pulmonary disease 274 (9.9) 48 (9.3) 126 (8.8) 52 (11.2) 48 (13.4) 0.05
Diabetes 788 (28.5) 120 (23.3) 381 (26.7) 176 (37.8) 111 (30.9) <0.001
Hypertension 1547 (56.0) 269 (52.3) 794 (55.7) 280 (60.1) 204 (56.8) 0.11
Stroke 95 (3.4) 10 (1.9) 46 (3.2) 20 (4.3) 19 (3.4) 0.04
Neurologic dysfunction 50 (1.8) 1(0.2) 32 (2.2) 8 (1.7) 9 (2.5) 0.02
Extracardiac arteriopathy 265 (9.6) 33 (6.4) 117 (8.2) 59 (12.7) 56 (15.6) <0.001
eGFR (mL/min/1.73 m2) 86.1±25.2 92.3±20.8 87.0±23.1 81.2±29.4 79.9±30.2 <0.001
Dialysis 22 (0.8) 1 (0.2) 8 (0.6) 3 (0.6) 10 (2.8) <0.001
Atrial fibrillation 282 (10.2) 7 (1.4) 159 (11.2) 64 (13.7) 52 (14.5) <0.001
Recent myocardial infarction 1319 (47.7) 144 (28.0) 652 (45.8) 307 (65.9) 216 (60.2) <0.001
Previous PCI 201 (7.3) 34 (6.6) 94 (6.6) 41 (8.8) 32 (8.9) 0.23
Previous cardiac surgery 46 (1.7) 6 (1.2) 17 (1.2) 11 (2.4) 12 (3.3) 0.02
Left ventricular ejection fraction <0.001
30-50% 612 (22.1) 81 (16.2) 284 (20.8) 131 (29.2) 116 (33.7)
<30% 87 (3.1) 4 (0.4) 39 (2.9) 28 (6.3) 16 (4.7)
Critical preoperative status 217 (7.9) 12 (2.3) 81 (5.7) 62 (13.3) 62 (17.3) <0.001
Operative data
Type of operation <0.001
Elective 1260 (45.6) 340 (66.1) 688 (48.3) 115 (24.7) 117 (32.6)
Urgent 1306 (47.3) 173 (33.7) 677 (47.5) 289 (62.0) 167 (46.5)
Emergency 197 (7.1) 1 (0.2) 60 (4.2) 62 (13.3) 75 (20.9)
Mammary artery graft 2642 (95.6) 508 (98.8) 1385 (97.2) 432 (92.7) 317 (88.3) <0.001
Potent antiplatelets within 5 days 512 (18.5) 37 (7.2) 242 (17.0) 139 (29.8) 94 (26.2) <0.001
Off-pump coronary surgery 1510 (54.6) 311 (60.5) 789 (55.4) 230 (49.4) 180 (50.1) 0.01
Number of distal anastomoses 4.0±1.1 4.0±1.1 3.9±1.1 4.0±1.1 3.8±1.0 0.07
In-hospital death 67 (2.4) 0 (0.0) 6 (0.4) 8 (1.7) 53 (14.8) <0.00121
Continuous variables are reported as mean and standard deviation. Categorical variables are reported as absolute 
number and percentages; eGFR: estimated glomerular filtration rate; PCI: percutaneous coronary intervention; OR: 
operating room. Definition criteria are according to EuroSCORE II.
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Table 2. E-CABG classification of postoperative complications or interventions for their treatment and their prevalence. Adjusted 
risk estimates for postoperative early and late mortality are reported.  
Grades Postoperative complications or interventions
for their treatment
Additive
score
No. (%) Adjusted
analysis for
mortality
HR (95%CI)
Multiple
propensity score
adjusted analysis
for mortality 
Grade 0
None of the below mentioned 
complications/interventions
0 514 (18.6) Reference
category
Reference
category
Grade 1 1425 (51.6) 1.76 (1.11-2.78) 1.69 (1.06-2.68)
Postoperative use of antibiotics                            2 937 (33.9)
Atrial fibrillation                                             2 1186 (42.9)
Transfusion of platelets                                        2 826 (29.9)
Transfusion of fresh frozen plasma or Octaplas 3 738 (26.7)
Transfusion of 2-4 units of RBC                              3 939 (34.0)
Deep wound infection of the leg                           3 78 (2.8)
Permanent pace-maker implantation                  3 18 (0.7)
Grade 2 466 (16.9) 2.70 (1.66-4.39) 2.71 (1.65-4.43)
Pericardial fenestration  for effusion       4 47 (1.7)
Acute kidney injury (dialysis excluded)     4 258 (89.3)*
Transfusion of 5-10 units of RBC                           5 443 (16.0)
Reoperation for bleeding                                        5 163 (5.9)
Deep sternal wound infection                                5 40 (1.4)
Postoperative IABP                                              5 16 (0.6)
Grade 3 359 (13.0) 5.08 (3.15-8.20) 4.57 (2.81-7.43)
Transfusion of > 10 units of RBC                            7 68 (2.5)
Acute kidney injury requiring dialysis 7 42 (1.5)*
Mediastinitis                                                   7 43 (1.6)
Stroke                                                          7 58 (21)
CABG or PCI for technical failure        7 14 (0.5)
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Reoperation for hemodynamic instability           8 168 (6.1)
Ventricular fibrillation/asystole                             8 49 (1.8)
Surgery for gastrointestinal complications          9 32 (1.2)
Postoperative ECMO                                             9 0 -
Definition criteria are according to the E-CABG criteria [10]; HR: hazard ratio; CI: confidence interval; RBC: red blood 
cell; IABP: intra-aortic balloon pump; CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; 
ECMO: extracorporeal membrane oxygenation; * patients on preoperative dialysis excluded from this analysis. 
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